Truist Lowers its Price Target on Insulet Corporation (PODD) to $360 and Maintains a Buy Rating
Market Intelligence Analysis
AI-Powered 90% GROQ-LLAMA-3.1-8B-INSTANTTruist lowered its price target on Insulet Corporation (PODD) to $360, maintaining a Buy rating, citing strong Q4 results driven by Omnipod 5's global success.
Market impact analysis based on bullish sentiment with 90% confidence.
Article Context
Insulet Corporation (NASDAQ:PODD) is among the 10 High Growth S&P 500 Stocks to Buy Now. Truist on February 19, 2026, lowered its price target on Insulet Corporation (NASDAQ:PODD) to $360 from $390 and maintained a Buy rating. The firm said Insulet delivered another strong Q4 beat, supported by broad global strength in Omnipod 5 as […]
AI Breakdown
Summary
Truist lowered its price target on Insulet Corporation (PODD) to $360, maintaining a Buy rating, citing strong Q4 results driven by Omnipod 5's global success.
Market Impact
Market impact analysis based on bullish sentiment with 90% confidence.
Time Horizon
Short Term
Analysis and insights provided by AnalystMarkets AI.